Clinical Trial Update: Long-term Impact of NMDAR Encephalitis, Level 3

View source ↗

Summary

A Level 3 clinical trial assessing the long-term impact of anti-NMDA receptor encephalitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-nmda Receptor Encephalitis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: NMDAR Autoimmune Encephalitis | Status: RECRUITING